Lyme disease. NIH gears up to test a hotly disputed theory.
Marshall
E
E
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D015748:Borrelia burgdorferi Group / Q000472:pathogenicity; D002908:Chronic Disease; D018849:Controlled Clinical Trials as Topic; D006801:Humans; D008193:Lyme Disease / Q000188:drug therapy* / Q000382:microbiology; D009316:National Institutes of Health (U.S.); D010344:Patient Advocacy; D014481:United States
D000900:Anti-Bacterial Agents